The multi-identity has revealed himself yet again (though we already knew) and wants us to let him have it.

Happy to oblige.

There is no obligation for the company to give specifics on clinical trial sites, date of initiation of dosing, or the other things that are helpful to short sellers and their minions, in their efforts to paint every positive development as being purportedly negative.

When someone comes here trying to provoke controversy over something that is a non-issue, then they reveal their true agenda.

Thanks for coming out in the open. Now those who were wondering whether they were being overly vigilant know that in fact their suspicions were true.